Related Experiment Video

Updated: Jul 18, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

Tolerizing DNA vaccines for autoimmune arthritis

Peggy P Ho1, John P Higgins, Brian A Kidd

  • 1Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94305, USA.

Autoimmunity
|December 21, 2006
PubMed

Insights

New antigen-specific tolerizing DNA vaccines effectively treat collagen-induced arthritis (CIA) in mice. This approach, enhanced by atorvastatin, shows promise for autoimmune disease therapies by reducing pro-inflammatory cytokines and autoantibody responses.

Area of Science:

  • Immunology
  • Vaccinology
  • Autoimmune Diseases

Background:

  • Current rheumatoid arthritis (RA) therapies non-specifically suppress immunity, highlighting the need for antigen-specific tolerizing treatments.
  • Developing targeted therapies is crucial for managing autoimmune diseases effectively.

Purpose of the Study:

  • To develop and evaluate antigen-specific tolerizing DNA vaccines for treating collagen-induced arthritis (CIA) in a mouse model.
  • To utilize protein microarrays for monitoring therapeutic responses and identifying new autoimmune targets.

Main Methods:

  • Developed tolerizing DNA vaccines encoding type II collagen (CII).
  • Administered vaccines to mice with CIA, with some receiving atorvastatin.
  • Analyzed cytokine production (IFN-gamma, TNF-alpha) from T cells.
  • Used arthritis microarray analysis to assess autoantibody responses.

Main Results:

  • Tolerizing DNA vaccines encoding CII significantly reduced CIA incidence and severity.
  • Atorvastatin potentiated the therapeutic effect of the CII DNA vaccines.
  • Vaccine treatment led to reduced production of pro-inflammatory cytokines IFN-gamma and TNF-alpha.
  • Microarray analysis showed decreased autoantibody spreading in treated mice.

Conclusions:

  • Antigen-specific tolerizing DNA vaccines are a promising strategy for treating CIA and potentially other autoimmune diseases like RA.
  • Antibody profiling is valuable for guiding the design and monitoring of these novel vaccine therapies.

More Related Videos

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity10:10

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Published on: November 8, 2016

Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase (G6PI)-Induced RA Mice08:43

Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase (G6PI)-Induced RA Mice

Published on: January 31, 2020

Related Concept Videos

Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...